COMMUNIQUÉS West-GlobeNewswire

Fluidigm Announces Conference Call and Webcast of Third Quarter 2018 Financial Results

01/10/2018 - 22:15

SOUTH SAN FRANCISCO, Calif., Oct. 01, 2018 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ:FLDM), a leader in mass cytometry and microfluidics technologies, announced today that it will report third quarter financial [...]

Aduro Biotech Announces Four Abstracts Accepted for Presentation at the 2018 Society for Immunotherapy of Cancer (SITC) Annual Meeting

01/10/2018 - 22:05

Preliminary Phase 1 data for novel STING pathway activator ADU-S100 (MIW815) accepted for presentation BERKELEY, Calif., Oct. 01, 2018 (GLOBE NEWSWIRE) -- Aduro Biotech, Inc. (NASDAQ: ADRO) today announced that four [...]

Aclaris Therapeutics Launches Direct-to-Consumer Campaign for ESKATA® (hydrogen peroxide) Topical Solution 40%, (w/w)

01/10/2018 - 22:01

ESKATA is the First and Only FDA-Approved Topical Treatment for Raised Seborrheic Keratoses WAYNE, Pa., Oct. 01, 2018 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ:ACRS), a dermatologist-led biopharmaceutical [...]

GW Pharmaceuticals Announces Proposed Public Offering of ADSs

01/10/2018 - 22:01

LONDON and CARLSBAD, Calif., Oct. 01, 2018 (GLOBE NEWSWIRE) -- GW Pharmaceuticals plc (Nasdaq: GWPH, “GW,” “the Company” or “the Group”), a biopharmaceutical company focused on discovering, developing and [...]

Merit Medical Signs Agreement to Acquire Cianna Medical, Inc.

01/10/2018 - 22:01

SOUTH JORDAN, Utah, Oct. 01, 2018 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading manufacturer and marketer of proprietary disposable devices used in interventional, diagnostic and therapeutic [...]

Allscripts to present at the 2018 Cantor Fitzgerald Global Healthcare Conference

01/10/2018 - 22:01

CHICAGO, Oct. 01, 2018 (GLOBE NEWSWIRE) -- Allscripts (NASDAQ: MDRX) today announced that certain members of its management team will present at the 2018 Cantor Fitzgerald Global Healthcare Conference in New York, NY on [...]

Paratek Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

01/10/2018 - 22:01

BOSTON, Oct. 01, 2018 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. (Nasdaq: PRTK), a biopharmaceutical company focused on the development and commercialization of innovative therapies based upon tetracycline [...]

Align Technology to Announce Third Quarter 2018 Results on October 24, 2018

01/10/2018 - 22:00

SAN JOSE, Calif., Oct. 01, 2018 (GLOBE NEWSWIRE) -- Align Technology, Inc. (Nasdaq: ALGN) announced today that the Company will report third quarter 2018 financial results on Wednesday, October 24, 2018 after the close [...]

Independent, Long-Term Study Highlights Effectiveness of iCAD's Xoft Electronic Brachytherapy System for Early-Stage Breast Cancer Treatment

01/10/2018 - 20:35

Retrospective trial utilizing intraoperative radiation therapy with the revolutionary Xoft System shows recurrence rates to be comparable to cornerstone TARGIT-A Trial at mean follow-up 4.6 years NASHUA, N.H., Oct. 01, [...]

Essilor et Delfin finalisent le rapprochement d'Essilor et de Luxottica en créant EssilorLuxottica, un leader mondial de l'optique ophtalmique et de la lunetterie

01/10/2018 - 19:01

Essilor et Delfin finalisent le rapprochement d'Essilor et de Luxottica en créant EssilorLuxottica, un leader mondial de l'optique ophtalmique et de la lunetterie Version PDF du communiqué EssilorLuxottica regroupe deux [...]

SAVI SCOUT® Highlighted as a Cutting Edge Technology for Breast Cancer Patients in 2018

01/10/2018 - 18:25

ALISO VIEJO, Calif., Oct. 01, 2018 (GLOBE NEWSWIRE) -- The SCOUT® Radar Breast Localization System was featured as the 2018 cutting edge technology for breast cancer patients as Good Morning America kicked off Breast [...]

Sanofi: Disclosure of trading in own shares

01/10/2018 - 18:01

Attachment Reporting EN.pdf

Sanofi : Déclaration des transactions sur actions propres

01/10/2018 - 18:01

Pièce jointe Reporting FR.pdf

Ossur Hf : Transactions in relation to share buyback program

01/10/2018 - 18:01

Announcement no. 57/2018 1 October 2018 Transactions in relation to share buyback program On 5 March 2018, Össur hf. initiated a share buy-back program, see Company announcement no. 16/2018. The purpose of the share [...]

OSE Immunotherapeutics to Present at the 18th Annual Biotech in Europe Investor Forum

01/10/2018 - 18:00

Oct. 4-5, 2018, Congress Center Basel NANTES, France, Oct. 01, 2018 (GLOBE NEWSWIRE) -- OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnémo: OSE) announced today that Alexis Peyroles, chief executive officer, will [...]

NICOX : MONTHLY PUBLICATION OF THE NUMBER OF SHARES COMPOSING THE SHARE CAPITAL AND OF THE TOTAL NUMBER OF VOTING RIGHTS

01/10/2018 - 17:46

Nicox SA Société anonyme with a registered capital of € 29,715,320 Head Office: DRAKKAR D 2405 route des Dolines 06560 Valbonne Sophia-Antipolis R.C.S. GRASSE 403.942.642 On October 1, 2018, MONTHLY PUBLICATION OF THE [...]

NICOX : PUBLICATION MENSUELLE DU NOMBRE D'ACTIONS COMPOSANT LE CAPITAL ET DU NOMBRE TOTAL DE DROITS DE VOTE

01/10/2018 - 17:46

Nicox SA Société anonyme au capital de 29 715 320 euros Siège social : DRAKKAR D 2405 route des Dolines 06560 Valbonne Sophia-Antipolis R.C.S. GRASSE 403.942.642 Le 1 octobre 2018, PUBLICATION MENSUELLE DU NOMBRE D' [...]

Jounce Therapeutics Founder Dr. James P. Allison Jointly Awarded 2018 Nobel Prize in Physiology or Medicine for the Discovery of Cancer Therapy by Inhibition of Negative Immune Regulation

01/10/2018 - 17:39

CAMBRIDGE, Mass., Oct. 01, 2018 (GLOBE NEWSWIRE) -- Jounce Therapeutics, Inc. (NASDAQ: JNCE), a clinical-stage company focused on the discovery and development of novel cancer immunotherapies and predictive biomarkers, [...]

Easton Pharmaceuticals Is Short-Listed to Acquire an Interest in an Operating Casino and Hotel Resort in Loutraki, Greece with Revenues in Excess of 60 Million Euro Per Year

01/10/2018 - 17:38

TORONTO, ON, Oct. 01, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Easton Pharmaceuticals Inc. (OTC: EAPH ) announces that it has made it to the short-list to acquire an interest or participate in the acquisition of [...]